Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study

Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease

(2012) Thomas M. van Himbergen   ARCHIVES OF NEUROLOGY

Genome-Wide Association Study of Lp-PLA2 Activity and Mass in the Framingham Heart Study

(2010) Sunil Suchindran et al.   PLoS Genetics

Cardiovascular Risk Factors and Incident Alzheimer Disease

(2009) Christianna Purnell et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk

(2009) Fotios Drenos et al.   HUMAN MOLECULAR GENETICS

Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study

(2008) Renate Schnabel et al.   ATHEROSCLEROSIS

Impact of APOE status on cognitive maintenance in healthy elderly persons

(2008) Antoinette E. Zehnder et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent

(2008) Emile R. Mohler et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia

Influence of race and sex on lipoprotein-associated phospholipase A2 levels: Observations from the Dallas Heart Study

(2007) Emmanouil S. Brilakis et al.   ATHEROSCLEROSIS